Knowledge, attitude, and practice toward antiviral treatment of chronic hepatitis B among patients.

ABSTRACT: China has the largest number of hepatitis B patients globally, making early detection, intervention, and treatment crucial. This study assessed the knowledge, attitude, and practice (KAP) toward antiviral treatment among chronic hepatitis B (CHB) patients. A web-based cross-sectional study was conducted among hepatitis B patients at the author's Hospital, Tianjin, China, between October 2022 and January 2023. Primary outcomes were KAP scores (knowledge: 0-18, attitude: 0-35, practice: 0-50). Secondary outcomes included factors associated with KAP. A total of 457 hepatitis B patients participated. The Mean KAP scores were 9.70 ± 4.64 (knowledge), 24.00 ± 3.28 (attitude), and 38.85 ± 6.56 (practice). Factors independently associated with adequate knowledge included household income 5,000-10,

SUBMITTER: Zhang H 

PROVIDER: S-EPMC12569183 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature